Friday, July 21, 2017 11:28:50 PM
“What the small companies need to do is show proof of concept. You have to hit your endpoints,” said Marban.
There is a desperate need for new therapies to treat heart failure, a chronic condition that prevents the heart from pumping blood as it should. The number of American adults with the disease could top 8 million by 2030, up from 5.7 million in 2012, while the cost of treatment could more than double, from $31 billion to $70 billion.
Each firm is taking a different approach to reach the same goal: bolstering the deteriorated muscle.''
http://news.heart.org/clinging-to-the-promise-of-heart-stem-cell-therapy/
emit...
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM